Chris Ryan
Gilead Sciences (NASDAQ:GUILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and Descovy.
The lawsuit stemmed from research by Gilead (NASDAQ:GUILD) conducted with the US Centers for Disease Control and Prevention to determine whether
